Amiodarone: Value of programmed electrical stimulation and Holter monitoring

John Devens Fisher, Soo G. Kim, L. E. Waspe, D. R. Johnston

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The value of programmed electrical stimulation (PES) and Holter monitoring in the assessment of amiodarone efficacy was reviewed. Many physicians have been disturbed by the persistent inducibility of arrhythmias in patients treated with amiodarone, who nevertheless do very well during the follow-up period. Noninducibility was associated with a favorable prognosis among 366 VT patients. Eighty-eight (24%) were noninducible on amiodarone, and 10% of these had recurrences, vs 39% in patients who remained inducible. Further, increased difficulty of induction with PES or induction of a slower or better tolerated VT may indicate a favorable outlook, and add to the value of PES. Few papers rigorously employed Holter monitoring in the assessment of amiodarone. In general, suppression of previously frequent arrhythmias implies excellent protection for patients with benign arrhythmias and moderate protection with malignant arrhythmias. By Holter assessment in 186 VT patients, arrhythmias were suppressed in 114 (61%), and 18% of these had recurrences vs 50% in patients whose arrhythmias were not suppressed. Studies attempting to correlate the results of PES and Holter monitoring in the same patients are lacking and may prove useful.

Original languageEnglish (US)
Pages (from-to)422-435
Number of pages14
JournalPACE - Pacing and Clinical Electrophysiology
Volume9
Issue number3
StatePublished - 1986

Fingerprint

Ambulatory Electrocardiography
Amiodarone
Electric Stimulation
Cardiac Arrhythmias
Recurrence
Physicians

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Amiodarone : Value of programmed electrical stimulation and Holter monitoring. / Fisher, John Devens; Kim, Soo G.; Waspe, L. E.; Johnston, D. R.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 9, No. 3, 1986, p. 422-435.

Research output: Contribution to journalArticle

Fisher, John Devens ; Kim, Soo G. ; Waspe, L. E. ; Johnston, D. R. / Amiodarone : Value of programmed electrical stimulation and Holter monitoring. In: PACE - Pacing and Clinical Electrophysiology. 1986 ; Vol. 9, No. 3. pp. 422-435.
@article{31ffcebf4a3744fe80bfc66d62f3dd06,
title = "Amiodarone: Value of programmed electrical stimulation and Holter monitoring",
abstract = "The value of programmed electrical stimulation (PES) and Holter monitoring in the assessment of amiodarone efficacy was reviewed. Many physicians have been disturbed by the persistent inducibility of arrhythmias in patients treated with amiodarone, who nevertheless do very well during the follow-up period. Noninducibility was associated with a favorable prognosis among 366 VT patients. Eighty-eight (24{\%}) were noninducible on amiodarone, and 10{\%} of these had recurrences, vs 39{\%} in patients who remained inducible. Further, increased difficulty of induction with PES or induction of a slower or better tolerated VT may indicate a favorable outlook, and add to the value of PES. Few papers rigorously employed Holter monitoring in the assessment of amiodarone. In general, suppression of previously frequent arrhythmias implies excellent protection for patients with benign arrhythmias and moderate protection with malignant arrhythmias. By Holter assessment in 186 VT patients, arrhythmias were suppressed in 114 (61{\%}), and 18{\%} of these had recurrences vs 50{\%} in patients whose arrhythmias were not suppressed. Studies attempting to correlate the results of PES and Holter monitoring in the same patients are lacking and may prove useful.",
author = "Fisher, {John Devens} and Kim, {Soo G.} and Waspe, {L. E.} and Johnston, {D. R.}",
year = "1986",
language = "English (US)",
volume = "9",
pages = "422--435",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Amiodarone

T2 - Value of programmed electrical stimulation and Holter monitoring

AU - Fisher, John Devens

AU - Kim, Soo G.

AU - Waspe, L. E.

AU - Johnston, D. R.

PY - 1986

Y1 - 1986

N2 - The value of programmed electrical stimulation (PES) and Holter monitoring in the assessment of amiodarone efficacy was reviewed. Many physicians have been disturbed by the persistent inducibility of arrhythmias in patients treated with amiodarone, who nevertheless do very well during the follow-up period. Noninducibility was associated with a favorable prognosis among 366 VT patients. Eighty-eight (24%) were noninducible on amiodarone, and 10% of these had recurrences, vs 39% in patients who remained inducible. Further, increased difficulty of induction with PES or induction of a slower or better tolerated VT may indicate a favorable outlook, and add to the value of PES. Few papers rigorously employed Holter monitoring in the assessment of amiodarone. In general, suppression of previously frequent arrhythmias implies excellent protection for patients with benign arrhythmias and moderate protection with malignant arrhythmias. By Holter assessment in 186 VT patients, arrhythmias were suppressed in 114 (61%), and 18% of these had recurrences vs 50% in patients whose arrhythmias were not suppressed. Studies attempting to correlate the results of PES and Holter monitoring in the same patients are lacking and may prove useful.

AB - The value of programmed electrical stimulation (PES) and Holter monitoring in the assessment of amiodarone efficacy was reviewed. Many physicians have been disturbed by the persistent inducibility of arrhythmias in patients treated with amiodarone, who nevertheless do very well during the follow-up period. Noninducibility was associated with a favorable prognosis among 366 VT patients. Eighty-eight (24%) were noninducible on amiodarone, and 10% of these had recurrences, vs 39% in patients who remained inducible. Further, increased difficulty of induction with PES or induction of a slower or better tolerated VT may indicate a favorable outlook, and add to the value of PES. Few papers rigorously employed Holter monitoring in the assessment of amiodarone. In general, suppression of previously frequent arrhythmias implies excellent protection for patients with benign arrhythmias and moderate protection with malignant arrhythmias. By Holter assessment in 186 VT patients, arrhythmias were suppressed in 114 (61%), and 18% of these had recurrences vs 50% in patients whose arrhythmias were not suppressed. Studies attempting to correlate the results of PES and Holter monitoring in the same patients are lacking and may prove useful.

UR - http://www.scopus.com/inward/record.url?scp=0022877363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022877363&partnerID=8YFLogxK

M3 - Article

C2 - 2423985

AN - SCOPUS:0022877363

VL - 9

SP - 422

EP - 435

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 3

ER -